Clinical trial
Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT02898649 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- August 31, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced pancreatic cancer